Literature DB >> 15211505

The structural genomics experimental pipeline: insights from global target lists.

Nicholas O'Toole1, Marek Grabowski, Zbyszek Otwinowski, Wladek Minor, Miroslaw Cygler.   

Abstract

Structural genomics (SG) initiatives are currently attempting to achieve the high-throughput determination of protein structures on a genome-wide scale. Here we analyze the SG target data that have been publicly released over a period of 16 months to assess the potential of the SG initiatives. We use statistical techniques most commonly applied in epidemiology to describe the dynamics of targets through the experimental SG pipeline. There is no clear bottleneck among the key stages of cloning, expression, purification and crystallization. An SG target will progress through each of these steps with a probability of approximately 45%. Around 80% of targets with diffraction data will yield a crystal structure, and 20% of targets with HSQC spectra will yield an NMR structure. We also find the overlaps among SG targets: 61% of SG protein sequences share at least 30% sequence identity with one or more other SG targets. There is no significant difference in average structure quality among SG structures and other structures in the PDB determined by "traditional" methods, but on average SG structures are deposited to the PDB twice as quickly after X-ray data collection. Copyright 2004 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2004        PMID: 15211505     DOI: 10.1002/prot.20060

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  15 in total

1.  An analysis of core deformations in protein superfamilies.

Authors:  Alejandra Leo-Macias; Pedro Lopez-Romero; Dmitry Lupyan; Daniel Zerbino; Angel R Ortiz
Journal:  Biophys J       Date:  2004-11-12       Impact factor: 4.033

2.  New surface contacts formed upon reductive lysine methylation: improving the probability of protein crystallization.

Authors:  Pawel Sledz; Heping Zheng; Krzysztof Murzyn; Maksymilian Chruszcz; Matthew D Zimmerman; Mahendra D Chordia; Andrzej Joachimiak; Wladek Minor
Journal:  Protein Sci       Date:  2010-07       Impact factor: 6.725

Review 3.  Structural genomics: keeping up with expanding knowledge of the protein universe.

Authors:  Marek Grabowski; Andrzej Joachimiak; Zbyszek Otwinowski; Wladek Minor
Journal:  Curr Opin Struct Biol       Date:  2007-06-22       Impact factor: 6.809

4.  High-throughput crystallization-to-structure pipeline at RIKEN SPring-8 Center.

Authors:  Michihiro Sugahara; Yukuhiko Asada; Katsumi Shimizu; Hitoshi Yamamoto; Neratur K Lokanath; Hisashi Mizutani; Bagautdin Bagautdinov; Yoshinori Matsuura; Midori Taketa; Yuichi Kageyama; Naoko Ono; Yuko Morikawa; Yukiko Tanaka; Hiroki Shimada; Takanobu Nakamoto; Mitsuaki Sugahara; Masaki Yamamoto; Naoki Kunishima
Journal:  J Struct Funct Genomics       Date:  2008-08-02

Review 5.  Determination of protein structures--a series of fortunate events.

Authors:  Maksymilian Chruszcz; Alexander Wlodawer; Wladek Minor
Journal:  Biophys J       Date:  2008-04-25       Impact factor: 4.033

6.  Mass spectrometry guided in situ proteolysis to obtain crystals for X-ray structure determination.

Authors:  Tarun Gheyi; Logan Rodgers; Richard Romero; J Michael Sauder; Stephen K Burley
Journal:  J Am Soc Mass Spectrom       Date:  2010-07-07       Impact factor: 3.109

7.  To automate or not to automate: this is the question.

Authors:  M Cymborowski; M Klimecka; M Chruszcz; M D Zimmerman; I A Shumilin; D Borek; K Lazarski; A Joachimiak; Z Otwinowski; W Anderson; W Minor
Journal:  J Struct Funct Genomics       Date:  2010-06-06

8.  Data management in the modern structural biology and biomedical research environment.

Authors:  Matthew D Zimmerman; Marek Grabowski; Marcin J Domagalski; Elizabeth M Maclean; Maksymilian Chruszcz; Wladek Minor
Journal:  Methods Mol Biol       Date:  2014

Review 9.  Benefits of structural genomics for drug discovery research.

Authors:  Marek Grabowski; Maksymilian Chruszcz; Matthew D Zimmerman; Olga Kirillova; Wladek Minor
Journal:  Infect Disord Drug Targets       Date:  2009-11

10.  In situ proteolysis to generate crystals for structure determination: an update.

Authors:  Amy Wernimont; Aled Edwards
Journal:  PLoS One       Date:  2009-04-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.